Notice2023-25325

Agency Information Collection Activities; Proposed eCollection eComments Requested; Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
November 16, 2023

Issuing agencies

Justice Department

Abstract

The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on September 11, 2023, allowing for a 60-day comment period.

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 220 (Thursday, November 16, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 220 (Thursday, November 16, 2023)]
[Notices]
[Pages 78788-78789]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-25325]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0013]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Application for Permit To Import Controlled 
Substances for Domestic and/or Scientific Purposes

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA), Department of 
Justice (DOJ), will be submitting the following information collection 
request to the Office of Management and Budget (OMB) for review and 
approval in accordance with the Paperwork Reduction Act of 1995. This 
proposed information collection was previously published in the Federal 
Register on September 11, 2023, allowing for a 60-day comment period.

DATES: Comments are encouraged and will be accepted for 30 days until 
December 18, 2023.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Regulatory Drafting and Policy Support Section, Drug Enforcement 
Administration; Mailing Address: 8701 Morrissette Drive, Springfield, 
Virginia 22152; Telephone: (571) 362-3261, email: 
<a href="/cdn-cgi/l/email-protection#7003131f04045e115e1202191e1b03301415115e171f06"><span class="__cf_email__" data-cfemail="3c4f5f534848125d125e4e5552574f7c58595d125b534a">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the

[[Page 78789]]

proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number 1117-0013. This information collection request 
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view 
Department of Justice, information collections currently under review 
by OMB.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Controlled Substances Import/
Export Declaration.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: Application for Permit 
to Import Controlled Substances for Domestic and/or Scientific Purposes 
Pursuant to 21 U.S.C. 952.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract: Affected public (Primary): Business or other 
for-profit.
    Abstract: Section 1002 of the Controlled Substances Import and 
Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal 
Regulations (21 CFR), Sections 1312.11, 1312.12 and 1312.13 requires 
any person who desires to import controlled substances listed in 
schedules I or II, any narcotic substance listed in schedules III or 
IV, or any non-narcotic substance in schedule III which the 
Administrator has specifically designated by regulation in 
section1312.30, or any nonnarcotic substance in schedule IV or V which 
is also listed in schedule I or II of the Convention on Psychotropic 
Substances, must have an import permit. To obtain the permit to import 
controlled substances for domestic and or scientific purposes, an 
application for the permit must be made to DEA on DEA Form 357.
    5. Obligation to Respond: Mandatory per 21 CFR 1312.11
    6. Total Estimated Number of Respondents: 124.
    7. Estimated Time per Respondent: 0.26 minutes.
    8. Frequency: 9.
    9. Total Estimated Annual Time Burden: 264.35 hours.
    10. Total Estimated Annual Other Costs Burden: $0.
    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.

    Dated: November 8, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2023-25325 Filed 11-15-23; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on November 16, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.